Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Genet Dev. 1999 Feb;9(1):15-21.

The oncogenic activation of beta-catenin.

Author information

  • 1Onyx Pharmaceuticals, 3031 Research Drive, Richmond, California 94806, USA.


The activation of beta-catenin to an oncogenic state can result from the inactivation of the tumor suppressor adenomatous polyposis coli (APC), by direct mutation in the beta-catenin gene, or by the activation of wnt receptors. Once activated, beta-catenin most likely promotes tumor progression through its persistent interaction with one or more of its numerous downstream targets.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk